William G. Wierda, M.D., Ph.D.; The University of Texas MD Anderson Cancer Center; 5Live; #ASCO2021
5:42
Chronic Lymphocytic Leukemia
William G. Wierda, M.D., Ph.D.; The University of Texas MD Anderson Cancer Center; 5Live; #ASCO2021
Chronic Lymphocytic Leukemia Similar Videos
Similar Videos
-
Module 4: Emerging BTK Inhibitors_Matthew Davids, MD, MMSc_Catherine Coombs, MD_Anthony Mato, MD, MSCE
12:02
-
Module 3: Zanubrutinib for Hematologic Malignancies_Matthew Davids, MD, MMSc_Catherine Coombs, Anthony Mato, MD, MSCE
7:59
-
Module 2: Acalabrutinib for Hematologic Malignancies_Matthew Davids, MD, MMSc_Catherine Coombs, MD_Anthony Mato, MSCE
8:16
